For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Sage Therapeutics, Inc.

USPTO Granted Patents = 92

CIPO Patents = 5

EPO Patents = 44

Trademarks = 12

Forward Citations = 784

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Francesco Gerald Salituro (78 out of 177 patents)

Albert Jean Robichaud (73 out of 107 patents)

Boyd Lynn Harrison (64 out of 95 patents)

4. Gabriel Martinez Botella (63 out of 93 patents)

5. Richard Thomas Beresis (15 out of 27 patents)

6. Maria Jesus Blanco-Pillado (12 out of 12 patents)

7. Andrew Mark Griffin (12 out of 32 patents)

8. Marshall Lee Morningstar (8 out of 8 patents)

9. Stephen Jay Kanes (7 out of 7 patents)

10. Daniel La (7 out of 24 patents)

11. John Gregory Reid (5 out of 20 patents)

12. Kiran Reddy (3 out of 23 patents)

13. Paul Steven Watson (3 out of 23 patents)

14. Bret Berner (3 out of 65 patents)

15. Jian Wang (3 out of 4 patents)

Core Competencies:

Neuroactive Steroids

Oxysterols

CNS Disorders

Crystalline Steroids

Neuroactive Steroid Formulations

Epilepsy Treatment

Cyclic Group Substituted Steroids

19-Nor Steroids

C3,3-Disubstituted Steroids

C7 Substituted Oxysterols

C17, C20, and C21 Substituted Steroids

Heteroaryl Steroids

92 patents: Sort by Forward Citations

1. 12473327 - Neuroactive steroids, compositions and uses thereof (2025-11-18),

2. 12448409 - Oxysterols and methods of use thereof (2025-10-21),

3. 12421275 - Compositions and methods for treating CNS disorders (2025-09-23),

4. 12410210 - Neuroactive steroids and their methods of use (2025-09-09),

5. 12358942 - Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid (2025-07-15),

6. 12331070 - C7 substituted oxysterols and methods of use thereof (2025-06-17),

7. 12268697 - Oxysterols and methods of use thereof (2025-04-08),

8. 12264177 - Neuroactive steroids and their methods of use (2025-04-01),

9. 12252509 - Neuroactive steroids and their methods of use (2025-03-18),

10. 12201640 - 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof (2025-01-21),

11. 12180248 - Compositions and methods for treating CNS disorders (2024-12-31),

12. 12180247 - Oxysterols and methods of use thereof (2024-12-31),

13. 12129276 - Oxysterols and methods of use thereof (2024-10-29),

14. 12129275 - Neuroactive steroids, compositions, and uses thereof (2024-10-29),

15. 12122803 - Crystalline forms of a neuroactive steroid (2024-10-22),

Sage Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines to treat central nervous system disorders. The company's mission is to transform the lives of patients and redefine standard of care through the innovative use of its proprietary compounds.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

92 Patents

#30 in Cambridge, MA

#219 in Massachusetts

#3,919 in US

#8,102 in the World

Cambridge, MA, United States of America

Sage Therapeutics, Inc.

Forward Citations = 784

25 inventors:

Francesco Gerald Salituro (78 out of 177 patents)

Albert Jean Robichaud (73 out of 107 patents)

Boyd Lynn Harrison (64 out of 95 patents)

4. Gabriel Martinez Botella (63 out of 93 patents)

5. Richard Thomas Beresis (15 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…